Artificial intelligence tools in neuro-oncology demonstrate robust performance in detecting brain metastases and predicting clinical outcomes.
The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, addressing mammography's limitations in dense breast tissue. The test achieved 92.3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback